Background
==========

Glucose kinase/glucokinase (GlcK/Glk) (EC 2.7.1.2) is one of the first enzymes encountered along the glycolytic pathway. This enzyme is responsible for catalyzing the ATP/ADP-dependent phosphorylation of the sixth carbon position of glucose to glucose 6-phosphate. Unlike the bacterial and archaeal glucokinases, the closest eukaryotic glucokinase counterpart such as yeast hexokinase B and human hexokinase IV (HK4 or GCK) (EC 2.7.1.1) are well characterized. In fact, the protein structure of yeast hexokinase B (31% identical amino acid residues to human HK4) was deciphered more than two decades ago \[[@B1]\]. Sites for the glucose formed hydrogen bond in human HK4: T168, K169, N204, D205, N231, and E290 are conserved among eukaryotes \[[@B2]-[@B4]\]. However, these sites are not found in microbial glucokinases. HK4 is able to phosphorylate not only glucose, but also mannose, fructose, sorbitol, and glucosamine (for review, see reference \[[@B5]\]). Microbial glucokinase has its own unique glucose-binding domain, which maybe conserved among glucokinases. The domain seems highly specific for glucose.

We have previously cloned and characterized the *glcK*gene of *Bacillus subtilis*\[[@B6]\]. Replacement of ATP by ADP revealed no detectable glucokinase activity, neither did replacement of glucose by fructose, galactose, or mannose \[[@B6]\]. The GlcK protein was characterized by *K*~*m*~values for ATP and glucose of 0.77 mM and 0.24 mM, respectively \[[@B6]\]. The ATP binding-motif D \[ILV\]G \[GA\] \[T\] conserved for both GlcK and HK4 are located at the N-terminal \[[@B3]\]. The mechanism of Mg^2+^-ATP binding to GlcK has never been directly observed but rather proposed by their homology to the ATP-binding sites of HK4 \[[@B6]\]. Two recent 3-D protein structures of ADP-dependent glucokinases, belonging to hyperthermophilic archaeon, *Thermococcus litoralis*and *Pyrococcus horikoshii*, showed the Mg^2+^motif (NEXE) and the ADP/ATP-dependent kinases motif (\[SD\]TXG XGDX \[IF\]) \[[@B7],[@B8]\]. Interestingly, the *T. litoralis*and *P. horikoshii*glucokinases are similar to ATP-dependent kinases: *E. coli*ribokinase and human adenosine kinase \[[@B7]\]. As a consequence, those archaeal glucose-binding sites are similar to the ribokinase, while the specific glucose-binding sites for many bacterial glucokinases remain elusive. It turns out that the archaeal glucokinases, including the *Aeropyrum pernix*ATP dependent Glk, showed broad specificity for hexoses, such as fructose, mannose, glucosamine, *N*-acetylglucosamine, and *N*-mannosamine \[[@B9]\].

Glucokinases, which participate in carbon catabolite repression \[[@B10]-[@B13]\], contain the so-called ROK (repressor, ORF, kinase) \[[@B14],[@B15]\]. Two alternative ROK motifs have been suggested: \[LIVM\]X(2)G \[LIVMFCT\]GX \[GA\] \[LIVMFA\]X(8)GX(3--5) \[GATP\]X(2)G \[R KH\] \[[@B14],[@B15]\] and CXCGX(2)GX \[WILV\]EX \[YFVIN\]X \[STAG\] \[[@B9],[@B16]\]. Concha and Leon \[[@B16]\] further proposed cysteine (C) residues, especially those within the ROK motif, to be essential for the catalytic activity of glucokinase. These may also be required for glucose binding.

Here we describe the unexpected finding that the phylogenetic analysis provided two clusters of microbial glucokinases sequences, which are also distinguished by the presence or absence of the CXCGX(2)GCXE motif. Since *B. subtilis*GlcK contains this motif, the role of C residues within the motif as well as the remaining C residues was examined.

Results
=======

Glucose kinases/glucokinases (EC 2.7.1.2) comprise two lineages with or without a conserved CXCGX(2)GCXE motif
--------------------------------------------------------------------------------------------------------------

The 52 amino acid sequences that have been analyzed in this study were used to understand the relationship and the distinction between *B. subtilis*GlcK and other glucokinases. Multiple alignments of glucokinases showed a typical ATP binding site and ROK motif. However, phylogenetic analysis demonstrated two lineages of glucokinases (Fig. [1](#F1){ref-type="fig"}). The first lineage includes *B. subtlis*GlcK, which clustered with the 33 other glucokinases belonging primarily to Gram-positive bacteria and archaea. The lineage is indicated by three conserved C residues in the motif: CXCGX(2)GCXE (Fig. [2](#F2){ref-type="fig"}). In contrast, the second lineage does not contain this motif. All the glucokinases retain the conserved ATP binding motif. The well-characterized *E. coli*Glk (P46880) belongs to the second lineage and it has very low sequence identity (13.7%) to *B. subtilis*GlcK. Glucokinases in the second lineage generally have a sequence identity lower than 15.9% to the *B. subtilis*GlcK. Biochemical properties of glucokinases from both lineages are very similar but surprisingly the sequence identities among them are quite diverse. Therefore, it was intriguing to identify the role of the amino acid sequences that are uniquely conserved. Conserved C residues within the CXCGX(2)GCXE motif were of particular interest and maybe important for GlcK\'s enzymatic activity.

*B. subtilis*GlcK occurs in both monomeric and dimeric forms
------------------------------------------------------------

Purified *B. subtilis*GlcK enzyme in soluble fractions was obtained after over-expression in *E. coli*RB791. The *B. subtilis*GlcK produced in *E. coli*was active as indicated by the ability to phosphorylate glucose. Under the reducing condition, GlcK showed a monomeric band of 35-kDa (Fig. [3A](#F3){ref-type="fig"} no. 1), while a homodimeric band of 70-kDa appeared under oxidative condition (Fig. [3B](#F3){ref-type="fig"}). Both forms were also observed under denaturating (SDS-PAGE) electrophoresis in the absence of reducing agent (Fig. [3A](#F3){ref-type="fig"} no. 2). This finding was supported by MALDI-TOF MS analysis of the GlcK, which also demonstrated two peaks of 35.2 kDa and 70.4 kDa, except for the protonated form (17.6 kDa) (Fig. [3C](#F3){ref-type="fig"}).

The C175, C177, and C182 are essential for *B. subtilis*GlcK enzymatic activity
-------------------------------------------------------------------------------

Exploring the roles of specific amino acid residues is essential to understanding the structure and function of a protein. The *B. subtilis*GlcK consists of six C residues at positions 166, 175, 177, 182, 282, and 321. Three-conserved C residues at positions 175, 177, and 182 were detected as part of a distinctive amino acid sequence motif in the first lineage but not the second one. In order to understand the correlation of C residues with the protein\'s structure--function relationship, we replaced C with an A residue using site-directed mutagenesis. We then analyzed their enzymatic activity *in vivo*by functional complementation in *E. coli glk*mutant UE26. *E. coli*UE26 (*ptsG ptsM glk*) is unable to utilize glucose as carbon source and, therefore, forms colourless colonies on glucose-containing MacConkey plates, while the wild type forms red colonies. Since *E. coli*UE26 cannot transport glucose via phosphotransferase system, we supplemented the plates with 50 mM glucose and 100 mM fucose. Fucose leads to the induction of galactose permease, which can also transport glucose. This unphosphorylated glucose can then be metabolized only if it is converted to glucose 6-phosphate by glucokinase. Plasmids carrying the mutated *B. subtilis glcK*genes were transformed into *E. coli*UE26 and cultivated on MacConkey agar plates supplemented with glucose and fucose. As a positive control, plasmid carrying the wild type *glcK*was also transformed into *E. coli*UE26. Negative controls were *E. coli*UE26 alone and *E. coli*UE26 carrying the plasmid expressing GlcK^D10K^, in which D was replaced by K at the ATP binding motif. Wild type *B. subtilis glcK*in *E. coli*UE26 showed red colonies (Fig. [4](#F4){ref-type="fig"}). GlcK^C166A^, GlcK^C282A^, and GlcK^C321A^also produced red colonies similar to the wild type GlcK. These mutants showed various degrees of red colour, suggestive of differential enzymatic activity (Fig. [4](#F4){ref-type="fig"}). However, mutants GlcK^C175A^, GlcK^C177A^, and GlcK^C182A^showed colourless phenotypes, similar to the negative controls. This phenotype indicates a complete loss of glucokinase activity caused by the mutation (Fig. [4](#F4){ref-type="fig"}). This data suggests that C at position 175, 177, and 182 is essential for enzymatic activity of *B. subtilis*GlcK.

C321A mutation increases *B. subtilis*GlcK enzymatic activity, which maybe independent of the dimerization status
-----------------------------------------------------------------------------------------------------------------

In order to confirm the enzymatic activity of GlcK mutants, we overproduced and purified the wild type GlcK, GlcK^C166A^, GlcK^C282A^, and GlcK^C321A^from soluble protein fractions of *E. coli*RB791. Induction of mutant GlcK was done with 1 mM IPTG at OD~0.7~. Three hours after induction, proteins were harvested and subjected to AKTA Purifier using Ni^2+^-NTA column. A 1000 ml culture yielded about 1 mg of pure GlcK^C166A^and about 10--15 mg of pure wild type GlcK, GlcK^C282A^, or GlcK^C321A^. The purified proteins were then tested for glucokinase activity *in vitro*, by coupling the phosphorylation of glucose to the formation of NADPH by glucose 6-phosphate dehydrogenese. The GlcK^C166A^activity was 12.3 ± 6.2 μmol min^-1^(mg protein)^-1^, which was comparable to the wild type GlcK activity. The GlcK^C282A^activity, 26.0 ± 7.4 μmol min^-1^(mg protein)^-1^, was slightly higher than GlcK^C166A^and the wild type GlcK. However, GlcK^C321A^\'s activity was 5-fold higher than GlcK^C166A^\'s and the wild type\'s. This result was in agreement with the *in vivo*functional complementation assay. Mutants GlcK^C166A^and GlcK^C282A^displayed red phenotype of *E. coli*UE26 colonies similar to the wild type GlcK (Fig. [4](#F4){ref-type="fig"}). As the enzymatic activity was much higher than that of the wild type, the C321A mutation caused much darker red colonies (Fig. [4](#F4){ref-type="fig"}). Similar to the wild type GlcK, SDS-PAGE analysis showed that GlcK^C166A^, GlcK^C282A^, and GlcK^C321A^appeared both as monomers and as homodimers under the non-reducing condition. The data suggests that the enzymatic activity of GlcK was independent of the dimerization status. Therefore, the increasing enzymatic activity of the GlcK^C321A^may not correlate well with the dimerization status. Nevertheless, whether the GlcK activity is affected by different ratios of monomer to homodimer warrants further study.

To prove that there were conformational changes of GlcK^C282A^and GlcK^C321A^, which had higher enzymatic activity, we analysed the GlcK mutants with fluorescence spectroscopy. Since the GlcK contains six tryptophan (W) and five tyrosine (Y) residues, excitation wavelengths of 280 and 295 nm were used to obtain emission spectra of the protein. Subtraction of W spectrum at λ~ex.295~from the W-Y spectrum at λ~ex.280~was done in order to obtain the separated spectrum of Y according to Isaev-Ivanov *et al.*\[[@B17]\]. GlcK^C282A^as well as GlcK^C321A^showed significant increased fluorescence intensity compared to the GlcK^C166A^, which has similar spectra to the wild type GlcK. This observation is indicative of changes in their structure due to the C mutation at 282 or 321. Increasing fluorescence intensities, as shown by GlcK^C282A^and GlcK^C321A^(Fig. [5](#F5){ref-type="fig"}), were due to conformational changes by these mutants leading to the re-positioning of tryptophan (λ~ex.295~) and tyrosine (λ~ex.280--295~) residues. Conformational changes by GlcKC321A were more pronounced as shown, not just by higher fluorescence intensity, but also a shift towards higher wavelengths (red shift) of the emission peak with respect to the wild type GlcK, GlcK^C166A^, and GlcK^C282A^(Fig. [5A, 5C](#F5){ref-type="fig"}). The red shift indicates a phenomenon similar to the effect of solvent reorganization. The enhanced fluorescence suggests a quenching mechanism that involves the thiol of C residue. Both red shift and enhanced fluorescence imply a loosening of packing interactions in the core of the protein and co-localization of C residues as well as W/Y residues that contribute to fluorescence \[[@B18],[@B19]\]. In our case, these implications may cause an increased ability of glucokinase to phosphorylate glucose as shown by the increasing glucokinase activity of GlcK^C321A^(Fig. [4](#F4){ref-type="fig"}, [5](#F5){ref-type="fig"}).

Discussion
==========

We have shown that two lineages of glucokinases has evolved with the presence or absence of the CXCGX(2)GCXE motif. Glucokinase belongs to the ROK family with the hallmark \[LIVM\]X(2)G \[LIVMFCT\]GX \[GA\] \[LIVMFA\]X(8)GX(3--5) \[GATP\]X(2) G \[RKH\] motif \[[@B14],[@B15]\]. Park *et al.*, 2000 \[[@B20]\] reported that some glucokinases do not contain the ROK motif. In fact, most glucokinase sequences, retrieved by us, preserved the ROK motif. However, some of the ROK motifs belonging to the second lineage have one to four amino acid mutations. Within the ROK family, the *B. subtilis*GlcK was grouped together with *B. subtilis*Xyl repressor protein (XylR), putative *B. subtilis*fructokinase (YdhR), *Streptococcus mutans*fructokinase (ScrK) encoded within a sucrose regulon, and *Zymomonas mobilis*fructokinase (FruK) \[[@B14],[@B15]\]. Dahl *et al.*, 1995 \[[@B21]\] analyzed the interaction of fructose, fructose 6-phosphate, glucose, and glucose 6-phosphate on the binding of XylR into *xylO*. Interestingly, only glucose stimulated the XylR binding \[[@B21]\]. The XylR has a ROK motif and a CXCGX(2)GCXE motif. In contrast, *Z. mobilis*FruK, *B. subtilis*YdhR, and *S. mutans*ScrK contain ROK motifs but not the CXCGX(2)GCXE motif. Hence, the CXCGX(2)GCXE motif may correlate with glucose binding. This is a reasonable possibility considering that the GlcK mutants with cysteine substitution exhibited a loss of enzymatic activity (Fig. [4](#F4){ref-type="fig"}).

*B. subtilis*GlcK was present in both monomeric and dimeric forms (Fig. [3](#F3){ref-type="fig"}). Mutants GlcK^C166A^, GlcK^C282A^, and GlcK^C321A^were still able to form a homodimer as shown by SDS-PAGE, under non-reducing conditions. However, oxidation of GlcK led to the homodimer formation (Fig. [3B](#F3){ref-type="fig"}). The dimerization of GlcK is possibly due to the overall role of the ATPase domain. Proteins with the ATPase domain acquired the capacity to dimerize and bind to ATP in an active site between the two subunits \[[@B22]-[@B24]\]. The evidence for this comes from the overall structural symmetry between two domains of the ATPase as well as from the symmetric arrangement of the two phosphate binding loops \[[@B22]\]. The ATPase domain of GlcK is located between amino acid residues 6 -- 27: FAGIDLGGTTIKLAFINQYGEI (phosphate 1), 109 -- 126: IENDANIAALGEMWKGAGDG (connect 1), 135 -- 149: VTLGTGVGGGIIANG (phosphate 2), 255 -- 282: PSKIVLGGGVSRAGELLRSKVEKTFRKC (adenosine), and 295 -- 308: IAALGNDAGVIGGA (connect 2).

Conclusions
===========

Multiple alignments and phylogenetic analysis had led directly to valuable insights into the possible molecular function and the evolution of glucokinase. This study enabled us to classify microbial glucokinases into two distinct lineages, with or without the CXCGX(2)GCXE motif. The experimental study also identified the role of C residues in *B. subtilis*GlcK. The three-conserved C residues in that motif are clearly essential for GlcK activity. However, the C321A mutation led to higher GlcK^C321A^enzymatic activity with respect to the wild type\'s, suggesting more adequate glucose phosphorylation.

Methods
=======

Bacterial strains, plasmids, and growth conditions
--------------------------------------------------

Bacterial strains and plasmids used in this work are shown in Table [1](#T1){ref-type="table"}. Both *B. subtilis*and *E. coli*were grown at 37°C in LB medium supplemented with the appropriate antibiotics.

Multiple sequence alignments and phylogenetic analysis
------------------------------------------------------

Sequences for eukaryotic, bacterial and archaeal glucokinases and putative glucokinases were retrieved from the GenBank database. Those sequences were aligned using the Clustal method \[[@B25]\] with the MegAlign 4.0 program (DNAStar Co., Madison, WI). To confirm the conservative domain, the obtained CXCGX(2)GCXE motif was used as template for BLAST searching \[[@B26]\]. Neighbor joining distance trees of microbial glucokinases were produced using the phylogenetic package MEGA2 \[[@B27]\]. Amino acid differences between sequences were corrected for multiple substitutions using a gamma correction. In this correction, α, the shape parameter of the gamma distribution, was set to 2. Therefore, the distance between any two amino sequences is approximately equal to Dayhoff\'s PAM distance per site \[[@B27]\]. Support for the nodes within phylogenetic tree were evaluated by the bootstrap \[[@B28]\], which was done in 500 replicates of the whole data set.

Site-directed mutagenesis
-------------------------

D10K, C166A, C175A, C177A, C182A, C282A, or C321A was introduced in the *glcK*gene of *B. subtilis*using the Excite™ PCR-based site directed mutagenesis kit (Stratagene, LA Jolla, CA). The constructed plasmids were pLM-GlcK \[D22K\], pLM-GlcK \[C178A\], pLM-GlcK \[C187A\], pLM-GlcK \[C189A\], pLM-GlcK \[C194A\], pLM-GlcK \[C294A\], and pLM-GlcK \[C333A\] (Table [1](#T1){ref-type="table"}). The coding sequences of the mutated *glcK*s were verified by DNA sequencing. Sequences of primers used to introduce the desired amino acid exchange are shown in Table [2](#T2){ref-type="table"}. In brief, the amplified DNA fragment was subjected to *Dpn*I digestion, which removed the pMD496 template DNA. Mutant plasmids were transformed into Epicurian Coli^®^XL1-Blue super-competent cells (Stratagene, La Jolla, CA) and plated on LB medium supplemented with ampicillin (100 μg ml^-1^).

DNA sequencing
--------------

Pure plasmids, carrying either *glcK*or one of its mutants (Table [1](#T1){ref-type="table"}), were prepared with the Nucleobond Midiprep kit according to the manufacturers suggestions (Macherey-Nagel, Dueren, Germany). Nucleotide sequences were determined by the cycle sequencing technique using the automated capillary sequencer, ABI PRISM 310/377 (Perkin Elmer Co., Foster City, CA). Sequencing primers used were: 5\'CGGATAA CAATTTCACACAG3\', 5\'CTTCT GAGGTCATTACTGG3\', 5\'GCTGCGCTCGGGG AAATGTG3\', and 5\'GATACGCCGCCGCCAAGAAC3\'. DNA analysis was carried out by DNAStar software (DNAStar Co., Madison, WI).

Protein overproduction and purification
---------------------------------------

Overexpression of \[His\]~6~-tagged-GlcK \[[@B6]\] and its mutated GlcKs was accomplished in *E. coli*RB791 harbouring the corresponding plasmids (Table [1](#T1){ref-type="table"}). Cells were harvested three hours after induction with 0.1 mM IPTG at an OD~600~of \~0.7. The pellet was then resuspended and sonicated in lysis buffer (150 mM NaCl and 20 mM Tris-Cl pH 7.5). Over-produced soluble proteins were purified from the supernatant as previously described \[[@B6]\]. The crude extract of cells was quickly passed over a Ni^2+^-loaded HiTrap chelating column (Pharmacia, Freiburg, Germany), which had been equilibrated with 40 column volumes of washing buffer (200 mM NaCl, 20 mM Imidazole and 5 mM Tris-Cl pH 7.5). Pure protein was eluted by a linear gradient using elution buffer (200 mM NaCl, 500 mM Imidazole and 5 mM Tris-Cl pH 7.5) at a flow rate of 0.5 ml min^-1^. Eluted protein aliquots of 0.5 ml were analysed on 12% SDS-PAGE. The GlcK concentration was determined by absorption measurement at 280 nm in 50 mM Tris-Cl pH 7.

*In vivo*functional complementation of *B. subtilis*GlcK mutants in *E. coli*UE26
---------------------------------------------------------------------------------

*E. coli*strain UE26 (*ptsG ptsM glk*) was transformed with plasmids carrying wild type *glcK*or *glcK*mutants. *In vivo*glucokinase activities were observed by monitoring colonies\' colour shift from white to red on MacConkey agar. The agar was supplemented with 50 mM glucose and 100 mM fucose \[[@B6]\].

*In vitro*assay of glucokinase activity
---------------------------------------

Enzymatic activity of wild type or mutated GlcK was quantified *in vitro*by a method described previously \[[@B6]\]. Specific glucokinase activity was determined in a coupled enzyme assay by the method of Seno and Charter \[[@B29]\] in a solution consisting of 50 mM Tris-HCl pH 7.5, 20 mM glucose, 25 mM MgCl~2~, 0.5 mM NADP, 1 mM ATP, and 1 U of glucose 6-phosphate dehydrogenase (G6PDH). The G6PDH activity was assayed by monitoring the change in the optical density at 340 nm at 32°C with NADP as a cofactor.

Analysis of protein multimerization with SDS PAGE, oxidative cross-linking, and MALDI-TOF mass spectrometry
-----------------------------------------------------------------------------------------------------------

GlcK was subjected to reducing or non-reducing conditions by using loading buffer (0.1% Bromphenolblue, 16% Glycerol, 4% SDS, and 55 mM Tris-Cl pH 6.8) with or without 10% β-mercaptoethanol. The samples were analysed on 12% SDS-PAGE. Oxidative cross-linking was carried out either with H~2~O~2~or with a complex of Cu(II) and 1,10-phenantroline. The procedure for the oxidative cross-linking of glucokinase was carried out as previously described \[[@B30]\] using 10 μg of glucokinase and analysing using an 8% SDS-PAGE. In order to remove the reductant, samples were dialyzed for several hours at 4°C in buffer (5 mM Tris-Cl pH 8.4, 1 mM EDTA and 1 mM DTT) containing 8 M, 5 M, or without urea \[[@B31]\]. Multimerization and molecular mass determination of *B. subtilis*GlcK was performed on a Biflex™ III Matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) (Bruker Daltonik GmbH, Bremen, Germany) equipped with a nitrogen laser at λ = 337 nm at the Institute for Biochemistry, University of Erlangen-Nuremberg.

Fluorescence measurement
------------------------

Fluorescence studies, carried out on a Spex Fluorolog spectrometer (Edison, NJ, USA), were used to determine spectral changes of GlcK and its mutants. The excitation wavelength was set to 280 nm or 295 nm and the emission was recorded in the range of 300 nm to 450 nm. For these measurements, the slit widths were set to 2.2 mm. Fluorescence measurements were carried out at 22°C.
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![Phylogenetic tree of 52 microbial glucokinases. The phylogenetic tree shows two lineages of glucokinases, depicted as blue and red branches. Each of these lineages received high bootstrap support. Bootstrap values (500 sample runs) are expressed in percentage. GenBank accession number for each glucokinase is provided.](1471-2180-4-6-1){#F1}

![A representative of microbial glucokinases from two lineages shows the presence or absence of the CXCGX(2)GCXE motif. *B. subtilis*\[[@B6]\], *B. megaterium*\[[@B11]\], *C. glutamicum*\[[@B20]\], *R. salmoninarum*\[[@B16]\], *S. coelicolor*\[[@B34]\], *B. abortus*\[[@B35]\], *E. coli*\[[@B36]\], and *Z. mobilis*\[[@B37]\] glucokinases are followed by their GenBank accession numbers.](1471-2180-4-6-2){#F2}

![*B. subtilis*GlcK can form a homodimer molecule. (A) GlcK dimerization is shown on 12% SDS-PAGE under reducing condition (1) and non-reducing condition (2). Molecular mass standard 70L (Sigma, Deisenhofen, Germany) with indicated size was used. (B) Cross-link experiment of GlcK was separated on an 8% polyacrylamide gel under non-reducing condition. Non-cross linked GlcK (1) demonstrates both monomeric and homodimeric form of GlcK (\*), oxidized GlcK with 1% H~2~O~2~(2), and 10 mM CuSO~4~.2H~2~O and 30 mM 1,10-phenantroline (3) shows only the homodimer. A MALDI-TOF mass spectrum shows the homodimer (70.4 kDa) and monomer (35.2 kDa) of GlcK. The 17.6 kDa peak is the protonated form of the sample.](1471-2180-4-6-3){#F3}

![Morphology of *E. coli*UE26 (*ptsG ptsM glk*) colonies expressing *B. subtilis*GlcK and its mutants on 50 mM glucose MacConkey agar supplemented with 100 mM fucose.](1471-2180-4-6-4){#F4}

![Fluorescence emission spectra of *B. subtilis*GlcK, GlcK^C166A^, GlcK^C282A^, and GlcK^C321A^, which were measured at excitation wavelength 280 nm (A), 295 nm (B), and subtraction of 280--295 nm. Samples (2.0 μM) were measured at 22°C in 50 mM Tris-Cl, pH 7.5. The spectra have been corrected by the buffer values. Experiments had been repeated three times.](1471-2180-4-6-5){#F5}

###### 

Bacterial strains and plasmids used in this study.

  **Strains and plasmids**   **Relevant genotype or phenotype**                                           **Reference or source**
  -------------------------- ---------------------------------------------------------------------------- -------------------------
  Strains                                                                                                 
  *B. subtilis*168           wild type                                                                    BGSC^a^, 1A1
  *E. coli*                                                                                               
  RB791                      F\' \[*lacI*^q^*L8*\] *hsdR*^+^*hsdM*                                        \[[@B32]\]
  UE26                       F^-^*ptsG2 ptsM1 glk7 rpsL150*                                               \[[@B33]\]
  Plasmids                                                                                                
  pMD496                     pQE9 derivative carrying *glcK*fused in frame to the His tag-coding region   \[[@B6]\]
  pLM-GlcK \[D22K\]          pMD496 derivative carrying *glcKD10K*                                        This study
  pLM-GlcK \[C178A\]         pMD496 derivative carrying *glcKC166A*                                       This study
  pLM-GlcK \[C187A\]         pMD496 derivative carrying *glcKC175A*                                       This study
  pLM-GlcK \[C189A\]         pMD496 derivative carrying *glcKC177A*                                       This study
  pLM-GlcK \[C194A\]         pMD496 derivative carrying *glcKC182A*                                       This study
  pLM-GlcK \[C294A\]         pMD496 derivative carrying *glcKC282A*                                       This study
  pLM-GlcK \[C333A\]         pMD496 derivative carrying *glcKC321A*                                       This study

^a^BGSC, *Bacillus*Genetic Stock Center, Ohio State University, Columbus, Ohio

###### 

Sets of primers used for site-directed mutagenesis in this study

  **Mutation**   **Primer sets^a^**
  -------------- --------------------------------------------------------------
  D10K           5\' tgcgggcatt[**a**]{.ul}a[**g**]{.ul}ctgggaggaacgacgat 3\'
                 5\' aaccatatctcgtccatggatccgtgatgg 3\'
  C166A          5\' ggccatatt[**gc**]{.ul}cagcatccctgaaggcgga 3\'
                 5\' gatttctccgccggcgccatttataccatg 3\'
  C175A          5\' gcgccc[**gc**]{.ul}caactgcggcaaaacgggctgt 3\'
                 5\' tccgccttcagggatgctgcaaatatggcc 3\'
  C177A          5\' tgcaac[**gc**]{.ul}cggcaaaacgggctgtatcgaa 3\'
                 5\' gggcgctccgccttcagggatgctgcaaat 3\'
  C182A          5\' ggcaaaacgggc[**gc**]{.ul}tatcgaaacaattgcg 3\'
                 5\' gcagttgcagggcgctccgccttcagggat 3\'
  C282A          5\' cgcaaa[**gc**]{.ul}cgcgtttccgcgggcagcccaa 3\'
                 5\' gaatgttttctcgacttttgatctcagcag 3\'
  C321A          5\' catcaaaat[**gc**]{.ul}ttaaaattgtgtaaatgaa 3\'
                 5\' tttcagccattcatttttagcgatccaagc 3\'

^a^Underlined is mutated nucleotide.
